The global Cancer Immunotherapy Drug Discovery Outsourcing market size is expected to be worth around US$ 2.7billion by 2030, according to a new report by Vision Research Reports.
The global Cancer Immunotherapy Drug Discovery Outsourcing market size was valued at US$ 717.6 million in 2020 and is anticipated to grow at a CAGR of 23.5% during forecast period 2021 to 2030.
Increasing prevalence of cancer and rising mortality associated with cancer, along with growing development in the field of cancer immunotherapy, are anticipated to stimulate the growth of the market.
In order to maintain pace with the increasing competition in the cancer therapeutics industry, pharmaceutical companies spend 2.5% more than other high tech industries in the in-house R&D. Hence, they are swiftly shifting toward the outsourcing of drug discovery in order to achieve lower in-house R&D costs.
Additionally, favorable tax credit allows pharmaceutical companies to appropriately plan their global projects with a reputed CRO and therefore, receive benefits and reduce problems associated with taxation authorities or other bodies administering such incentive programs.
Several new molecules for cancer immunotherapy and new immunotherapeutic options, such as tumor-infiltrating lymphocytes, checkpoint inhibitors immunomodulators, and CAR-T cell therapy, have been introduced. Some are in the pipeline and are being tested for their ability to provide better cancer treatment
The monoclonal antibodies segment was the most prominent medicine type in 2020. Proved efficacy of monoclonal antibodies and the introduction of enhanced drug types such as bispecific, naked antigen-binding, and conjugated monoclonal antibodies are attracting the attention of pharmaceutical companies.
Cancer vaccines and oncolytic viral therapies are breakthrough innovations in the field of cancer immunotherapy owing to constant R & D efforts of market participants. This immunotherapeutic vaccine includes immune cells of patients converted to dendritic cells by chemical treatment, used against prostate cancer. A few treatment vaccines in the pipeline constitute parts of cells, antigens, and cancer cells.
Therapeutic vaccines have been observed to create anti-cancer antigen acting memory cells in the immune system of the affected individuals. Rising awareness regarding benefits associated with these vaccines has been boosting investments of market players in R & D activities. Therefore, cancer vaccines and oncolytic viral therapies are poised to post the fastest growth over the forecast period.
Growing focus on novel therapeutic options is resulting in the advancement of therapeutic options such as CAR T cell therapies, immune checkpoint inhibitors, and tumor-infiltrating lymphocytes. These therapies are showing promising results in clinical studies of leU.K.emia and lymphomas. However, side effects associated with these therapies such as extremely high fever and life-threatening low blood pressure issues can impede the growth.
Lung cancer accounted for the leading market share in 2017. Late diagnosis of this condition makes chemotherapy inefficient for the treatment of patients. This drawback can be overcome by immunotherapy as it has proved to have remarkable effects on NSCLC (non-small cell lung cancer) conditions. In addition, the availability of the majority of immunotherapies for NSCLC has been supplementing the growth of the segment.
Ovarian cancer is likely to exhibit the highest CAGR during the forecast period owing to increasing R & D investments and rising prevalence. Immunotherapies have shown positive results in the treatment of ovarian cancer as it enhances the patient’s immune system, in turn, prohibiting the growth of malignant cells. Ovarian oncology’s treatment with immunotherapy includes checkpoint inhibitors and other adoptive therapies. Ongoing R & D in the field has several upcoming potential drugs for the treatment, which will spur the growth of the segment over the forecast period.
Immunotherapeutic advancements have been noticed in the case of several other types such as melanoma, head and neck, and prostate cancer. There are 3 immunotherapeutic drugs in the market for head and neck oncology, one target antibody molecule, cetuximab, and two checkpoint inhibitors, nivolumab, and pembrolizumab. Rising prevalence of these cancer types is responsible for encouraging investments in R & D of immunotherapeutic drugs, which in turn is revving up the adoption rate of outsourcing services.
Immunotherapy is one of the most promising oncological therapies with advantages such as fewer side effects, higher efficacy, and increased patient convenience over other treatment solutions. As a result, market players are investing heavily in R & D of immunotherapy-based interventions.
The target identification and validation segment dominated the overall market in 2020. It is projected to remain dominant throughout the forecast period. At present, cancer immunotherapy is in its nascent phase. However, the success of currently available immunotherapeutic agents has been drawing the attention of most of the big pharmaceutical companies to invest in new drug development. Thus, the market is anticipated to experience an upthrust with the launch of novel drugs, which is estimated to have a positive impact on early drug discovery procedures in the market.
North America held the largest revenue share in the market in 2020. The presence of key CROs and big pharmaceutical and biotech companies has been playing a vital in the growth of the regional market. Surging demand for novel drugs in immunotherapy and increasing outsourcing trend of drug discovery processes are estimated to help the region maintain its position in the global arena through 2025.
Several prominent global market players are headquartered in the U.S. These companies are increasing their global presence by setting up laboratories in Europe and Asia Pacific. These companies have certain advantages such as easy availability of advanced tools used in drug discovery, which enables them to complete the discovery process in a shorter time as compared to their competitors. All these factors have been working in favor of the market in North America.
Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation; Celentyx Ltd.; ImmunXperts SA; Personalis, Inc.; STC Biologics; and Molecular Imaging, Inc.
Drug Type Outlook
Oncolytic Viral Therapies and Cancer Vaccines
Service Type Outlook
Target Identification and Validation
Lead Screening and Characterization
Cancer Type Outlook
Head and Neck
Middle East & Africa
The Cancer Immunotherapy Drug Discovery Outsourcing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Cancer Immunotherapy Drug Discovery Outsourcing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Cancer Immunotherapy Drug Discovery Outsourcing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Immunotherapy Drug Discovery Outsourcing market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Cancer Immunotherapy Drug Discovery Outsourcing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Cancer Immunotherapy Drug Discovery Outsourcing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Cancer Immunotherapy Drug Discovery Outsourcing by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Cancer Immunotherapy Drug Discovery Outsourcing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Cancer Immunotherapy Drug Discovery Outsourcing market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Cancer Immunotherapy Drug Discovery Outsourcing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Cancer Immunotherapy Drug Discovery Outsourcing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Cancer Immunotherapy Drug Discovery Outsourcing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Cancer Immunotherapy Drug Discovery Outsourcing market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Cancer Immunotherapy Drug Discovery Outsourcing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Cancer Immunotherapy Drug Discovery Outsourcing market. These factors have benefited the growth of the global market for Cancer Immunotherapy Drug Discovery Outsourcing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Cancer Immunotherapy Drug Discovery Outsourcing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Cancer Immunotherapy Drug Discovery Outsourcing are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...